Curetopia has raised $1.77 million in funding to accelerate treatments for rare diseases using a decentralized biotech model with Solana. The project, supported by over 1,000 contributors, aims to address the underserved rare disease market, with a focus on patient engagement and tokenization. Their recent discovery for AARS2 progressive leukoencephalopathy is a promising step towards commercialization.

Leave a Reply